Fixed drug eruption is a common cutaneous adverse reaction in young patients with a characteristic clinical appearance. However, the diagnosis and identification of the substance may be difficult if food or food additives provoke the fixed eruption. A 26-year-old man had a history of two episodes of cutaneous erythema with residual pigmentation. Close examination of the history including his diet in addition to an oral challenge test and patch testing led to the diagnosis of fixed eruption secondary to quinine in tonic water. We examined for the presence of quinine in commercially available brands of tonic water using ultraviolet A and irradiation and high-performance liquid chromatography. Both Schweppes and CANADA DRY brands of tonic water emitted fluorescent light upon ultraviolet A irradiation, and contained quinine at concentrations of 67.9 and 61.3 mg/L, respectively. Quinine contained in some tonic waters may trigger fixed eruption.

Download full-text PDF

Source
http://dx.doi.org/10.1111/1346-8138.12195DOI Listing

Publication Analysis

Top Keywords

fixed eruption
16
tonic water
16
quinine tonic
8
high-performance liquid
8
liquid chromatography
8
brands tonic
8
ultraviolet irradiation
8
fixed
5
quinine
5
tonic
5

Similar Publications

Introduction: Deepbite is a vertical malocclusion found alone or in association with other types of sagittal and transverse disorders. With a high relapse tendency, deepbite is considered one of the most challenging malocclusions to treat. It is commonly found in mixed dentition with increased prevalence of 21.

View Article and Find Full Text PDF

Clinical cues for distinguishing bullous fixed drug eruption from Stevens-Johnson syndrome: A case report.

SAGE Open Med Case Rep

December 2024

Department of Dermatology, KCU-GME Consortium/Advanced Dermatology and Cosmetic Surgery, Orlando, FL, USA.

This case report discusses two clinical encounters of a 62-year-old Hispanic woman initially hospitalized with suspected Stevens-Johnson syndrome, later correctly diagnosed with bullous fixed drug eruption during an outpatient visit for a similar eruption. The first encounter involved an extensive evaluation and an 11-day hospital stay, while the second was managed successfully as an outpatient with oral prednisone. This report highlights the importance of differentiating bullous fixed drug eruption from Stevens-Johnson syndrome/toxic epidermal necrolysis and emphasizes the need for a collaborative approach between Primary Care Providers and Dermatology to ensure optimal patient care.

View Article and Find Full Text PDF

Class III malocclusion is one of the most challenging malocclusions in orthodontics. Its nature and multifactorial etiology should be taken into consideration, especially in growing and adolescent patients. Many treatment modalities have been proposed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!